{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T22:28:39Z","timestamp":1782944919704,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T00:00:00Z","timestamp":1472601600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12872-016-0351-y","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T15:36:16Z","timestamp":1472830576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cost-effectiveness analysis of left atrial appendage occlusion compared with pharmacological strategies for stroke prevention in atrial fibrillation"],"prefix":"10.1186","volume":"16","author":[{"given":"Vivian Wing-Yan","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald Bing-Ching","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines Hang-Iao","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan Ping-Yen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Gungor","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai-Wun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yat-Yin","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,31]]},"reference":[{"issue":"8","key":"351_CR1","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","volume":"22","author":"PA Wolf","year":"1991","unstructured":"Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22(8):983\u20138.","journal-title":"Stroke"},{"issue":"20","key":"351_CR2","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1056\/NEJMoa0901301","volume":"360","author":"SJ Connolly","year":"2009","unstructured":"Active Investigators, Connolly SJ, Pogue J, Hart RG, Hohnloser SH, Pfeffer M, Chrolavicius S, Yusuf S. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med. 2009;360(20):2066\u201378.","journal-title":"N Engl J Med"},{"key":"351_CR3","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, et al. Dabigatran versus Warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139\u201351.","journal-title":"N Engl J Med"},{"issue":"10","key":"351_CR4","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883\u201391.","journal-title":"N Engl J Med"},{"issue":"9689","key":"351_CR5","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","volume":"374","author":"DR Holmes","year":"2009","unstructured":"Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P, PA Investigators. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374(9689):534\u201342.","journal-title":"Lancet"},{"issue":"5","key":"351_CR6","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/ccd.22764","volume":"77","author":"JW Park","year":"2011","unstructured":"Park JW, Bethencourt A, Sievert H, Santoro G, Meier B, Walsh K, Lopez-Minquez JR, Meerkin D, Valdes M, Ormerod O, et al. Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience. Catheter Cardiovasc Interv. 2011;77(5):700\u20136.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"24","key":"351_CR7","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1016\/j.jacc.2015.09.084","volume":"66","author":"VY Reddy","year":"2015","unstructured":"Reddy VY, Akehurst RL, Armstrong SO, Amorosi SL, Beard SM, Holmes Jr DR. Time to cost-effectiveness following stroke reduction strategies in AF: warfarin versus NOACs versus LAA closure. J Am Coll Cardiol. 2015;66(24):2728\u201339.","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"351_CR8","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1161\/CIRCULATIONAHA.112.000920","volume":"127","author":"SM Singh","year":"2013","unstructured":"Singh SM, Micieli A, Wijeysundera HC. Economic evaluation of percutaneous left atrial appendage occlusion, dabigatran, and warfarin for stroke prevention in patients with nonvalvular atrial fibrillation. Circulation. 2013;127(24):2414\u201323.","journal-title":"Circulation"},{"key":"351_CR9","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195108248.001.0001","volume-title":"Cost-effectiveness in health and medicine","author":"MR Gold","year":"1996","unstructured":"Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996."},{"issue":"22","key":"351_CR10","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1161\/CIRCULATIONAHA.110.985655","volume":"123","author":"SV Shah","year":"2011","unstructured":"Shah SV, Gage BF. Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation. Circulation. 2011;123(22):2562\u201370.","journal-title":"Circulation"},{"issue":"25","key":"351_CR11","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1016\/j.jacc.2013.03.035","volume":"61","author":"VY Reddy","year":"2013","unstructured":"Reddy VY, Mobius-Winkler S, Miller MA, Neuzil P, Schuler G, Wiebe J, Sick P, Sievert H. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). J Am Coll Cardiol. 2013;61(25):2551\u20136.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"351_CR12","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1161\/CIRCULATIONAHA.110.976449","volume":"123","author":"VYMD Reddy","year":"2011","unstructured":"Reddy VYMD, Holmes DMD, Doshi SKMD, Neuzil PMDP, Kar SMD. Safety of percutaneous left atrial appendage closure: results from the watchman left atrial appendage system for embolic protection in patients with AF (PROTECT AF) clinical trial and the continued access registry. Circulation. 2011;123(4):417\u201324.","journal-title":"Circulation"},{"issue":"11","key":"351_CR13","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365(11):981\u201392.","journal-title":"N Engl J Med"},{"issue":"1","key":"351_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","volume":"64","author":"DR Holmes Jr","year":"2014","unstructured":"Holmes Jr DR, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, Huber K, Reddy VY. Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64(1):1\u201312.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"351_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-154-1-201101040-00289","volume":"154","author":"JV Freeman","year":"2011","unstructured":"Freeman JV, Zhu RP, Owens DK, Garber AM, Hutton DW, Go AS, Wang PJ, Turakhia MP. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Ann Intern Med. 2011;154(1):1\u201311.","journal-title":"Ann Intern Med"},{"issue":"6","key":"351_CR16","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1161\/STROKEAHA.111.000402","volume":"44","author":"AR Harrington","year":"2013","unstructured":"Harrington AR, Armstrong EP, Nolan Jr PE, Malone DC. Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation. Stroke. 2013;44(6):1676\u201381.","journal-title":"Stroke"},{"issue":"6","key":"351_CR17","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1001\/jama.293.6.699","volume":"293","author":"CL O'Brien","year":"2005","unstructured":"O'Brien CL, Gage BF. Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation. JAMA. 2005;293(6):699\u2013706.","journal-title":"JAMA"},{"issue":"6","key":"351_CR18","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.112.114389","volume":"127","author":"VY Reddy","year":"2013","unstructured":"Reddy VY, Doshi SK, Sievert H, Buchbinder M, Neuzil P, Huber K, Halperin JL, Holmes D. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial. Circulation. 2013;127(6):720\u20139.","journal-title":"Circulation"},{"issue":"2","key":"351_CR19","doi-asserted-by":"publisher","first-page":"220","DOI":"10.4244\/EIJV6I2A35","volume":"6","author":"YL Bayard","year":"2010","unstructured":"Bayard YL, Omran H, Neuzil P, Thuesen L, Pichler M, Rowland E, Ramondo A, Ruzyllo W, Budts W, Montalescot G, et al. PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study. EuroIntervention. 2010;6(2):220\u20136.","journal-title":"EuroIntervention"},{"key":"351_CR20","unstructured":"Reddy VY, Doshi SK, Sievert H, Buchbinder M, Neuzil P, Huber K, Kar S, Halperin JL, Whisenant B, Swarup V et al.: Long-term PROTECT-AF analysis: Watchman attains efficacy superiority over warfarin in AF. In: Heart Rhythm Society (HRS) 34th Annual Scientific Sessions. Denver, Colorado; May 2013."},{"issue":"16","key":"351_CR21","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1001\/archinte.1996.00440150083009","volume":"156","author":"BF Gage","year":"1996","unstructured":"Gage BF, Cardinalli AB, Owens DK. The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life. Arch Intern Med. 1996;156(16):1829\u201336.","journal-title":"Arch Intern Med"},{"issue":"4","key":"351_CR22","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1177\/0272989X06290495","volume":"26","author":"PW Sullivan","year":"2006","unstructured":"Sullivan PW, Ghushchyan V. Preference-Based EQ-5D index scores for chronic conditions in the United States. Med Decis Making. 2006;26(4):410\u201320.","journal-title":"Med Decis Making"},{"issue":"2","key":"351_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1177\/0272989X9301300202","volume":"13","author":"DG Fryback","year":"1993","unstructured":"Fryback DG, Dasbach EJ, Klein R, Klein BE, Dorn N, Peterson K, Martin PA. The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making. 1993;13(2):89\u2013102.","journal-title":"Med Decis Making"},{"issue":"9208","key":"351_CR24","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S0140-6736(00)90012-6","volume":"355","author":"R Thomson","year":"2000","unstructured":"Thomson R, Parkin D, Eccles M, Sudlow M, Robinson A. Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation. Lancet. 2000;355(9208):956\u201362.","journal-title":"Lancet"},{"key":"351_CR25","unstructured":"Centers for Medicare and Medicaid Services (CMS): Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long Term Care Hospital Prospective Payment System and Proposed Fiscal Year 2015 Rates. In. US: Department of Health and Human services (HHS) 2014: https:\/\/www.gpo.gov\/fdsys\/pkg\/FR-2014-05-15\/pdf\/2014-10067.pdf . Accessed 29 Aug 2016."},{"key":"351_CR26","unstructured":"American Society of Echocardiography. Coding and Reimbursement Newsletter. In.: American Medical Association: 2014. http:\/\/asecho.org\/wordpress\/wp-content\/uploads\/2014\/2006\/2014-reimbursement-newsletter-.pdf . Accessed 1 July 2014."},{"issue":"5","key":"351_CR27","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1378\/chest.10-0134","volume":"138","author":"R Pisters","year":"2010","unstructured":"Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010;138(5):1093\u2013100.","journal-title":"Chest"},{"issue":"1","key":"351_CR28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ijcard.2010.10.017","volume":"150","author":"YY Lam","year":"2011","unstructured":"Lam YY, Ma TKW, Yan BP. Alternatives to chronic warfarin therapy for the prevention of stroke in patients with atrial fibrillation. Int J Cardiol. 2011;150(1):4\u201311.","journal-title":"Int J Cardiol"},{"issue":"21","key":"351_CR29","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","volume":"33","author":"AJ Camm","year":"2012","unstructured":"Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33(21):2719\u201347.","journal-title":"Eur Heart J"},{"issue":"5","key":"351_CR30","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1002\/ccd.22344","volume":"75","author":"I Cruz-Gonzalez","year":"2010","unstructured":"Cruz-Gonzalez I, Yan BP, Lam YY. Left atrial appendage exclusion: state-of-the-art. Catheter Cardiovasc Interv. 2010;75(5):806\u201313.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"5","key":"351_CR31","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1002\/ccd.23136","volume":"79","author":"YY Lam","year":"2012","unstructured":"Lam YY, Yip GW, Yu CM, Chan WW, Cheng BC, Yan BP, Clugston R, Yong G, Gattorna T, Paul V. Left atrial appendage closure with AMPLATZER cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience. Catheter Cardiovasc Interv. 2012;79(5):794\u2013800.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"16","key":"351_CR32","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1161\/01.CIR.0000145172.55640.93","volume":"110","author":"BF Gage","year":"2004","unstructured":"Gage BF, van Walraven C, Pearce L, Hart RG, Koudstaal PJ, Boode BS, Petersen P. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation. 2004;110(16):2287\u201392.","journal-title":"Circulation"},{"issue":"2","key":"351_CR33","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/ccd.24872","volume":"82","author":"F Nietlispach","year":"2013","unstructured":"Nietlispach F, Gloekler S, Krause R, Shakir S, Schmid M, Khattab AA, Wenaweser P, Windecker S, Meier B. Amplatzer left atrial appendage occlusion: single center 10-year experience. Catheter Cardiovasc Interv. 2013;82(2):283\u20139.","journal-title":"Catheter Cardiovasc Interv"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-016-0351-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-016-0351-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-016-0351-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-016-0351-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T05:15:16Z","timestamp":1718774116000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-016-0351-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,31]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["351"],"URL":"https:\/\/doi.org\/10.1186\/s12872-016-0351-y","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,31]]},"article-number":"167"}}